Related Experiment Video
Updated: Aug 3, 2026
16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
Serotonergic lesions decrease mu- and delta-opiate receptor binding in discrete areas of the hypothalamus and in the
D L Allen1, A E Johnson, A Tempel
1Rockefeller University, Laboratory of Neuroendocrinology, New York, NY 10021.
Brain Research
|October 22, 1993
Summary
Serotonin pathways in the brain interact with opiate receptors. These interactions are crucial for regulating female sexual behavior and reproductive functions.
Area of Science:
- Neuroscience
- Neuroendocrinology
- Behavioral Neuroscience
Background:
- Serotonin plays a role in regulating various physiological and behavioral processes.
- Opiate receptors are involved in pain, reward, and reproductive functions.
Purpose of the Study:
- To investigate the interaction between serotonergic pathways and opiate receptor binding in brain regions controlling reproductive behavior.
- To determine the effect of serotonergic lesions on mu- and delta-opiate receptor levels and sexual behavior.
Main Methods:
- Selective neurotoxin 5,7-dihydroxytryptamine (5,7-DHT) was used to lesion serotonergic nerve terminals via intraventricular infusion.
- Mu- and delta-opiate receptor binding was quantified in specific brain areas, including the preoptic area (mPOA) and hypothalamus.
- The effect of hypothalamic serotonergic lesions on morphine-induced inhibition of female sexual behavior (lordosis) was assessed.
Main Results:
- Serotonergic lesions significantly decreased mu-opiate receptor binding in the preoptic area and midbrain central gray.
- Delta-opiate receptor binding was reduced in the preoptic area and dorsomedial hypothalamus following serotonergic lesions.
- Hypothalamic serotonergic lesions attenuated the inhibitory effect of morphine on female sexual behavior.
Conclusions:
- Evidence supports the existence of serotonergic-opiate interactions within specific brain regions.
- These neurochemical interactions are suggested to be important in the neurobiological regulation of female sexual behavior, specifically lordosis.
- Findings highlight the complex interplay between serotonin and opioid systems in reproductive neuroendocrinology.
More Related Videos
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...